Trials / Recruiting
RecruitingNCT03647072
PPI Versus Histamine Antagnists as Adjuvant to Chemotherapy
Comparative Clinical and Biochemical Study Evaluating the Effect of Proton Pump I Nhibitors Versus Histamine 2 Receptor Antagonists as an Adjuvant With Chemotherapy in Patients With Non-hodgkin Lymphoma.
- Status
- Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Sherief Abd-Elsalam · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study is a Comparative Clinical and Biochemical Study Evaluating the effect of Proton Pump I nhibitors versus histamine 2 Receptor antagonists as an adjuvant with chemotherapy in patients with Non-hodgkin Lymphoma.
Detailed description
The study is a Comparative Clinical and Biochemical Study Evaluating the effect of Proton Pump Inhibitors versus histamine 2 Receptor antagonists as an adjuvant with chemotherapy in patients with Non-hodgkin Lymphoma to compare the difference in efficacy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CHOP | CHOP only |
| DRUG | CHOP Plus Lanzoprazole | CHOP plus Lanzoprazole 60 mg |
| DRUG | CHOP Plus Famotidine | CHOP Plus Famotidine 40 mg |
Timeline
- Start date
- 2018-08-01
- Primary completion
- 2027-10-01
- Completion
- 2027-12-01
- First posted
- 2018-08-27
- Last updated
- 2018-08-27
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT03647072. Inclusion in this directory is not an endorsement.